NewAmsterdam Pharma Company N.V. (NAMSW) Financials

NAMSW Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 704.5 million 73.0 million
March 31, 2026 732.6 million 67.4 million
Dec. 31, 2025 769.3 million 85.9 million
Sept. 30, 2025 786.4 million 58.4 million

NAMSW Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -39.3 million 18.4 million
March 31, 2026 -30.6 million 18.0 million
Dec. 31, 2025 -41.0 million 14.0 million
Sept. 30, 2025 -32.8 million 15.0 million

NAMSW Net Income

No data available :(

NAMSW Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 633.9 million - 82000
March 31, 2026 636.1 million - 23000
Dec. 31, 2025 636.2 million 66000 202000
Sept. 30, 2025 702.9 million - 266000

NAMSW Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 123.4 million
March 31, 2026 121.1 million
Dec. 31, 2025 114.4 million
Sept. 30, 2025 119.0 million

NAMSW Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 80000 41.7 million 26.9 million -
March 31, 2026 38000 37.5 million 23.5 million -
Dec. 31, 2025 100000 38.6 million 27.4 million -
Sept. 30, 2025 42000 31.0 million 24.5 million -

NAMSW Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 3.7 million -
March 31, 2026 3.0 million 500000
Dec. 31, 2025 32000 59000
Sept. 30, 2025 348000 64000

NAMSW

Price: $16.51

52 week price:
10.27
30.45

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 3.2 billion

Links: